| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.009 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |